- Nachrichtendetail
-
28.06.2024 16:33:21 - dpa-AFX: *J&J : RYBREVANT COMBINATION APPROVED IN EUROPE FOR FIRST-LINE TREATMENT OF NSCLC
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Frankfurt | 135,880 | 02.07.24 18:44:14 | -0,120 | -0,09% | 0,000 | 0,000 | 135,840 | 136,000 |
